PMID: 19939231Nov 27, 2009Paper

Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid

Current Alzheimer Research
V FrisardiF Panza

Abstract

Pathological, genetic, biochemical and pharmacological studies support the hypothesis that brain accumulation of oligomeric species of beta-amyloid (Abeta) peptides may cause Alzheimer's disease (AD). Drugs currently used for the treatment of AD produce limited clinical benefits and do not treat the underlying causes of the disease. In the last 10 years, new therapeutic approaches targeting Abeta have been discovered and developed with the hope of modifying the natural history of the disease. Several active and passive immunotherapy approaches are under investigation in clinical trials with the aim of accelerating Abeta clearance from the brain of the AD patients. The most advanced of these immunological approaches is bapineuzumab, composed of humanized anti-Abeta monoclonal antibodies, that is being tested in two large late-stage trials. Compounds that interfere with proteases regulating Abeta formation from amyloid precursor protein (APP) are also actively pursued. Unfortunately, the most biologically attractive of these proteases, beta-secretase, that regulates the first step of the amyloidogenic APP metabolism, was found to be particularly problematic to block and only one compound (CTS21166) has reached clinical testing so...Continue Reading

Citations

Mar 27, 2012·Journal of Neuroimmunology·Mike Veenstra, Richard M Ransohoff
Sep 16, 2011·Neurology·S SallowayUNKNOWN ELND005-AD201 Investigators
Nov 26, 2010·Immunotherapy·Francesco PanzaVincenzo Solfrizzi
Oct 15, 2011·Cellular and Molecular Life Sciences : CMLS·Akhlaq A FarooquiVincenza Frisardi
Oct 5, 2011·The Journal of Nutrition, Health & Aging·F PanzaA Pilotto
May 5, 2011·Expert Review of Neurotherapeutics·Vincenzo SolfrizziAlberto Pilotto
Feb 1, 2012·Expert Review of Clinical Immunology·Bruno P ImbimboFrancesco Panza
Apr 4, 2012·Expert Opinion on Drug Discovery·Grazia D'OnofrioAlberto Pilotto
Jan 13, 2011·Expert Opinion on Pharmacotherapy·Kanwaljit ChopraAnurag Kuhad
Apr 20, 2011·Expert Opinion on Biological Therapy·Francesco PanzaAlberto Pilotto
Jan 13, 2011·Expert Opinion on Investigational Drugs·Bruno P ImbimboAlberto Pilotto
Jul 2, 2014·Expert Opinion on Biological Therapy·Francesco PanzaGiancarlo Logroscino
Apr 9, 2011·New Biotechnology·Pavan K Krishnamurthy, Einar M Sigurdsson
Jan 25, 2011·Trends in Pharmacological Sciences·Alan M Palmer
May 7, 2010·Ageing Research Reviews·Vincenza FrisardiFrancesco Panza
Apr 13, 2010·Brain Research·Irfan A QureshiMark F Mehler
Apr 13, 2011·Journal of Neurodevelopmental Disorders·Elizabeth Berry-KravisCrystal Hervey
Oct 31, 2015·Neurodegenerative Disease Management·Jennifer G GoldmanCynthia D Schroeder
Jun 22, 2010·CNS Neuroscience & Therapeutics·Francesco PanzaVincenzo Solfrizzi
Aug 6, 2013·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Aiko TodaHeii Arai
Oct 2, 2012·Angewandte Chemie·Drew S FolkKatherine J Franz
Jan 26, 2013·Journal of Peptide Science : an Official Publication of the European Peptide Society·Wei ZhangJianting Miao
Jun 12, 2013·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Pimporn InsainSupaporn Kradtap Hartwell
May 12, 2015·Trends in Pharmacological Sciences·Miao-Kun SunDaniel L Alkon
Nov 27, 2015·The Indian Journal of Medical Research·Neelum T AggarwalDavid A Bennett
Sep 15, 2014·Neurobiology of Aging·Jieqiong ChenMichael Janitz
Apr 10, 2015·PloS One·Elisa TamburoLuigi Maria Edoardo Grimaldi
Jul 20, 2016·BioMed Research International·Francesco PanzaGiancarlo Logroscino
Dec 6, 2011·Progress in Neurobiology·Antero SalminenIrina Alafuzoff
Aug 4, 2016·Immunotherapy·Francesco PanzaGiancarlo Logroscino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

© 2022 Meta ULC. All rights reserved